Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Suggested Reading
Mann SJ, Pickering TG. Detection of renovascular hypertension: State of the art.
Ann Intern Med.
1992;117:845.
PLASMINOGEN
*
Definition
Plasminogen is the inactive, circulating precursor of plasmin, the final product of the fibrinolytic system. Therapy with plasminogen activators results in the generation of plasmin and intended thrombolysis.
![]()
Normal range:
70–113%.
Interpretation
Decreased In
Congenital: rare reported cases; may result in a predisposition to thrombosis
Acquired: severe DIC, pathologic fibrinolysis, or as the result of thrombolytic therapy, and in liver disease
PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI 1)
*
Definition
PAI 1, an inhibitor of plasminogen activation is synthesized in endothelial cells, in platelets, and by the liver.
![]()
Normal range:
0.0–22.0 IU/mL.
Use
This test may be used in rare cases with a tendency to thrombosis when no other cause is identified.
Interpretation
Decreased Values
Difficult to determine because the normal range can be as low as 0.0